2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome
Elias Jabbour, Srdan Verstovsek, Francis Giles, Varsha Gandhi, Jorge Cortes, Susan O'Brien, William Plunkett, Guillermo Garcia-Manero, C. Ellen Jackson, Hagop Kantarjian, Michael Andreeff*
Dive into the research topics of '2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome'. Together they form a unique fingerprint.